James Investment Research Inc. cut its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 28.2% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 42,080 shares of the company’s stock after selling 16,524 shares during the quarter. James Investment Research Inc.’s holdings in Procter & Gamble were worth $6,113,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in PG. Baxter Bros Inc. purchased a new stake in Procter & Gamble in the second quarter worth approximately $12,381,000. Empowered Funds LLC purchased a new stake in Procter & Gamble during the 2nd quarter valued at $53,549,000. Bank of America Corp DE purchased a new stake in Procter & Gamble during the 2nd quarter valued at $3,850,628,000. Rokos Capital Management LLP bought a new position in shares of Procter & Gamble during the 1st quarter valued at $29,914,000. Finally, Capstone Capital Management Ltd bought a new position in shares of Procter & Gamble during the 3rd quarter valued at $991,000. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble News Roundup
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
- Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
- Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
- Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
- Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on the company. HSBC restated a “hold” rating and issued a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a research note on Thursday, July 30th. BMO Capital Markets increased their target price on Procter & Gamble from $169.00 to $170.00 and gave the company an “outperform” rating in a report on Monday, June 29th. Sanford C. Bernstein reissued a “market perform” rating and issued a $149.00 target price on shares of Procter & Gamble in a research report on Monday, August 24th. JPMorgan Chase & Co. raised their target price on Procter & Gamble from $162.00 to $180.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, BNP Paribas Exane upped their price target on shares of Procter & Gamble from $177.00 to $189.00 and gave the company an “outperform” rating in a research report on Friday. Fifteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average price target of $168.90.
Get Our Latest Stock Report on Procter & Gamble
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CFO Andre Schulten sold 3,914 shares of the business’s stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $568,860.76. Following the completion of the sale, the chief financial officer owned 65,618 shares of the company’s stock, valued at approximately $9,536,920.12. The trade was a 5.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Matthew Janzaruk sold 359 shares of the business’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $145.24, for a total value of $52,141.16. Following the sale, the chief accounting officer directly owned 1,271 shares of the company’s stock, valued at $184,600.04. This represents a 22.02% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 15,135 shares of company stock valued at $2,189,970 in the last ninety days. Corporate insiders own 0.23% of the company’s stock.
Procter & Gamble Stock Down 2.6%
PG opened at $161.21 on Friday. The company has a current ratio of 0.72, a quick ratio of 0.47 and a debt-to-equity ratio of 0.40. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $167.25. The company has a market capitalization of $374.43 billion, a PE ratio of 24.28, a PEG ratio of 4.11 and a beta of 0.39. The firm’s 50 day simple moving average is $148.41 and its two-hundred day simple moving average is $147.09.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, topping the consensus estimate of $1.89 by $0.11. Procter & Gamble had a net margin of 18.23% and a return on equity of 30.91%. The business had revenue of $23.28 billion for the quarter, compared to analysts’ expectations of $22.80 billion. During the same quarter last year, the company posted $1.99 EPS. The company’s revenue was up 4.0% compared to the same quarter last year. As a group, equities analysts forecast that Procter & Gamble Company will post 6.98 EPS for the current year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date is Friday, October 23rd. This represents a $4.35 annualized dividend and a yield of 2.7%. Procter & Gamble’s payout ratio is 65.71%.
Procter & Gamble Profile
Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
Read More
- Five stocks we like better than Procter & Gamble
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
- Chefs’ Warehouse Has Rallied 76%—Can the Stock Keep Climbing?
- MarketBeat Week in Review – 10/19 – 10/23
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
